Research
-
Completed
April 2021 - May 2023
Development of novel antimicrobial therapy for Acanthamoeba Keratitis
Researchers seek to develop novel HDPs with enhanced efficacy and safety to treat Acanthamoeba Keratitis (AK).
-
Completed
December 2014 - November 2015
Why is Acanthamoeba keratitis on the rise?
Understanding the causes of an emerging threat to sight.
-
Completed
March 2016 - March 2017
Acanthamoeba under the microscope
Finding out who will need longer treatment to save their sight.
-
Active
October 2021 - September 2024
Identifying genetic causes leading to Keratitis infection in UK patients
The aim of the study is to determine whether different types of isolates respond differently to drugs used to prevent or treat Acanthamoeba infection.